Work

Heterogeneity in subgroup reporting across clinical trials assessing systemic therapies in metastatic castration resistant prostate cancer: A report from a living systematic review.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.270

Authors: Muhammad Umair Anjum, Syed Arsalan Ahmed Naqvi, Kaneez Zahra Rubab Khakwani, Ammad Raina, Salman Ayub Jajja, Muhammad Ali Khan, Bryan Rumble, Rohan Garje, Yousef Zakharia, Parminder Singh, Rahul Atul Parikh, Alan Haruo Bryce, Irbaz Bin Riaz

Institutions: Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona), University of Arizona, Canandaigua VA Medical Center, American Society of Clinical Oncology, Baptist Hospital of Miami, Baptist Health South Florida, University of Kansas Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407678563

Cites:

Cited by:

Related to: 10